Risk management plan is a complex document that aims to improve the benefit-risk balance of medicinal product. It describes pharmacovigilance activities and interventions designed to identify, characterize, and manage risks relating to a medicinal product.

Due to complexity of the risk management plan, its creation requires multidisciplinary expertise. Biomapas can offer you the expertise of clinical, pharmacovigilance and regulatory specialists ensuring that the advice on risk evaluation and the proposed measures for prevention and risk minimization are relevant and thorough.